JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AFB
5076
AllianceBernstein National Municipal Income Fund
AFB
$271M
| $108K | ﹤0.01% |
+10,283
| New | +$107K |
2022 Q4
0 quarters
|
|
5077
Enel Chile
ENIC
$5.96B
| $108K | ﹤0.01% |
+48,202
| New | +$88.6K |
2022 Q4
0 quarters
|
|
5078
Blue Bird Corp
BLBD
$1.79B
| $107K | ﹤0.01% |
9,955
+309
| +3% | +$3.1K |
2017 Q4
20 quarters
|
|
5079
FT Vest US Equity Buffer ETF August
FAUG
$1.43B
| $107K | ﹤0.01% |
+3,080
| New | +$107K |
2022 Q4
0 quarters
|
|
5080
Grab Holdings Warrant
GRABW
$660K
| – | – |
0
| – | – |
2021 Q4
4 quarters
|
|
5081
WisdomTree Europe SmallCap Dividend Fund
DFE
$162M
| $106K | ﹤0.01% |
1,931
+200
| +12% | +$10.3K |
2014 Q2
34 quarters
|
|
5082
DNP Select Income Fund
DNP
$3.59B
| $106K | ﹤0.01% |
+9,359
| New | +$102K |
2022 Q4
0 quarters
|
|
5083
Groupon
GRPN
$802M
| $106K | ﹤0.01% |
12,376
+420
| +4% | +$3.25K |
2013 Q2
38 quarters
|
|
|
VLD
5084
DELISTED
Velo3D, Inc.
VLD
| $106K | ﹤0.01% |
1,688
+156
| +10% | +$15.2K |
2021 Q3
5 quarters
|
|
|
CPTK
5085
DELISTED
Crown PropTech Acquisitions
CPTK
| $106K | ﹤0.01% |
10,494
-1,470
| -12% | -$14.7K |
2021 Q2
6 quarters
|
|
5086
Garrett Motion
GTX
$4.98B
| $105K | ﹤0.01% |
13,691
+11,699
| +587% | +$82.2K |
2021 Q2
6 quarters
|
|
5087
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
| $105K | ﹤0.01% |
+3,447
| New | +$104K |
2022 Q4
0 quarters
|
|
|
BSLK
5088
DELISTED
Bolt Projects Holdings
BSLK
| $105K | ﹤0.01% |
525
-7,869
| -94% | -$1.57M |
2021 Q2
6 quarters
|
|
|
WHWK
5089
Whitehawk Therapeutics
WHWK
$211M
| $105K | ﹤0.01% |
8,232
+319
| +4% | +$4.17K |
2022 Q2
2 quarters
|
|
|
ALPN
5090
DELISTED
Alpine Immune Sciences Inc
ALPN
| $105K | ﹤0.01% |
14,230
+3,657
| +35% | +$23.4K |
2021 Q2
6 quarters
|
|
|
BBU
5091
DELISTED
Brookfield Business Partners
BBU
| $104K | ﹤0.01% |
6,145
+153
| +3% | +$2.97K |
2016 Q2
26 quarters
|
|
|
EOS
5092
Eaton Vance Enhance Equity Income Fund II
EOS
$1.13B
| $104K | ﹤0.01% |
6,280
-1,735
| -22% | -$29K |
2022 Q2
2 quarters
|
|
5093
UWM Holdings
UWMC
$445M
| $104K | ﹤0.01% |
31,414
+25,075
| +396% | +$94K |
2021 Q2
6 quarters
|
|
|
AOD
5094
abrdn Total Dynamic Dividend Fund
AOD
$1.08B
| $103K | ﹤0.01% |
+13,226
| New | +$102K |
2022 Q4
0 quarters
|
|
5095
Distribution Solutions Group
DSGR
$1.62B
| $103K | ﹤0.01% |
5,586
-436
| -7% | -$7.32K |
2016 Q4
24 quarters
|
|
5096
Kodak
KODK
$982M
| $103K | ﹤0.01% |
33,649
+1,279
| +4% | +$5.62K |
2017 Q4
20 quarters
|
|
5097
Entrada Therapeutics
TRDA
$213M
| $103K | ﹤0.01% |
+7,593
| New | +$133K |
2022 Q4
0 quarters
|
|
|
GRTS
5098
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $103K | ﹤0.01% |
29,921
+25,138
| +526% | +$71.8K |
2018 Q3
17 quarters
|
|
5099
Quantum-Si Incorporated
QSI
$280M
| $102K | ﹤0.01% |
55,653
-2,648
| -5% | -$6.82K |
2021 Q4
4 quarters
|
|
5100
CALL
Scorpio Tankers
STNG
$4.33B
| $102K | ﹤0.01% |
1,900
-27,500
| -94% | -$1.37M |
2022 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.